Structure-based drug design of an inhibitor of the SARS-CoV-2 (COVID-19) main protease using free software: A tutorial for students and scientists

S Zhang, M Krumberger, MA Morris… - European journal of …, 2021 - Elsevier
This paper describes the structure-based design of a preliminary drug candidate against
COVID-19 using free software and publicly available X-ray crystallographic structures. The …

Diversifying amino acids and peptides via deaminative reductive cross-couplings leveraging high-throughput experimentation

JC Twitty, Y Hong, B Garcia, S Tsang… - Journal of the …, 2023 - ACS Publications
A deaminative reductive coupling of amino acid pyridinium salts with aryl bromides has
been developed to enable efficient synthesis of noncanonical amino acids and …

Building on success: a bright future for peptide therapeutics

Y Angell, M Holford, WH Moos - Protein and peptide letters, 2018 - ingentaconnect.com
The primary aim of this review article is to highlight current exciting and future looking areas
of research in peptide science as applied to the discovery and development of novel …

NanoClick: a high throughput, target-agnostic peptide cell permeability assay

A Peier, L Ge, N Boyer, J Frost, R Duggal… - ACS Chemical …, 2021 - ACS Publications
Macrocyclic peptides open new opportunities to target intracellular protein–protein
interactions (PPIs) that are often considered nondruggable by traditional small molecules …

A cyclic peptide inhibitor of the SARS-CoV-2 main protease

AG Kreutzer, M Krumberger, EM Diessner… - European journal of …, 2021 - Elsevier
This paper presents the design and study of a first-in-class cyclic peptide inhibitor against
the SARS-CoV-2 main protease (M pro). The cyclic peptide inhibitor is designed to mimic the …

Macrocyclic α helical peptide therapeutic modality: A perspective of learnings and challenges

TK Sawyer, AW Partridge, HYK Kaan, YC Juang… - Bioorganic & Medicinal …, 2018 - Elsevier
Macrocyclic α-helical peptides have emerged as a compelling new therapeutic modality to
tackle targets confined to the intracellular compartment. Within the scope of hydrocarbon …

Electrochemical sensing of the peptide drug exendin-4 using a versatile nucleic acid nanostructure

N Khuda, S Somasundaram, CJ Easley - ACS sensors, 2022 - ACS Publications
Although endogenous peptides and peptide-based therapeutics are both highly relevant to
human health, there are few approaches for sensitive biosensing of this class of molecules …

Development and regulatory challenges for peptide therapeutics

D Zane, PL Feldman, T Sawyer, Z Sobol, J Hawes - 2021 - journals.sagepub.com
There has been an increased interest in and activity for the use of peptide therapeutics to
treat a variety of human diseases. The number of peptide drugs entering clinical …

Molecular Mechanism of P53 Peptide Permeation through Lipid Membranes from Solid-State NMR Spectroscopy and Molecular Dynamics Simulations

M Li, J Li, X Lu, R Schroder… - Journal of the …, 2024 - ACS Publications
Macrocyclic peptides show promise in targeting high-value therapeutically relevant binding
sites due to their high affinity and specificity. However, their clinical application is often …

Plasma metabolites-based design of long-acting peptides and their anticancer evaluation

C Zhang, X Li, Z Xing, H Zhong, D Yu, R Yu… - International Journal of …, 2023 - Elsevier
Antimicrobial peptides (AMPs) are generally small cationic amphipathic peptides, which are
thought to be ideal antineoplastic agents, owing to their favorable selectivity to cancer cells …